Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | microphthalmia-associated transcription factor | Starlite/ChEMBL | No references |
Homo sapiens | isocitrate dehydrogenase 1 (NADP+), soluble | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | isocitrate dehydrogenase | 0.0019 | 0.0288 | 0.0709 |
Schistosoma mansoni | ferritin | 0.001 | 0.0108 | 0.0108 |
Echinococcus multilocularis | expressed protein | 0.001 | 0.0108 | 0.0033 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0648 | 0.0648 |
Schistosoma mansoni | apoferritin-2 | 0.001 | 0.0108 | 0.0108 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0288 | 0.0215 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0019 | 0.0288 | 0.0216 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0288 | 0.0699 |
Echinococcus multilocularis | transcription factor eb | 0.013 | 0.2564 | 0.2508 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0787 | 0.0787 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0288 | 0.0706 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0019 | 0.0288 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0787 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0288 | 0.0215 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1129 | 0.4142 |
Trichomonas vaginalis | ferritin, putative | 0.001 | 0.0108 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0787 | 0.0718 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.074 | 0.2552 |
Schistosoma mansoni | ferritin | 0.001 | 0.0108 | 0.0108 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.1129 | 0.4142 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.1028 | 0.0961 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0288 | 0.5 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.0648 | 0.0648 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0288 | 0.0215 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.1028 | 0.3741 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0288 | 0.0216 |
Schistosoma mansoni | ferritin light chain | 0.001 | 0.0108 | 0.0108 |
Loa Loa (eye worm) | hypothetical protein | 0.013 | 0.2551 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.1028 | 0.3728 |
Schistosoma mansoni | ferritin | 0.001 | 0.0108 | 0.0108 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0118 | 0.0044 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0288 | 0.5 |
Echinococcus granulosus | cpg binding protein | 0.0037 | 0.0648 | 0.0578 |
Echinococcus multilocularis | cpg binding protein | 0.0037 | 0.0648 | 0.0578 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0066 | 0.1242 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0288 | 0.0699 |
Mycobacterium ulcerans | bacterioferritin BfrA | 0.001 | 0.0108 | 0.5 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0019 | 0.0288 | 0.0288 |
Echinococcus granulosus | ferritin | 0.001 | 0.0108 | 0.0033 |
Onchocerca volvulus | 0.0035 | 0.0608 | 0.5 | |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0288 | 0.0288 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0288 | 0.0288 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0019 | 0.0288 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.1028 | 0.0961 |
Mycobacterium leprae | PROBABLE BACTERIOFERRITIN BFRA | 0.001 | 0.0108 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0787 | 0.0718 |
Schistosoma mansoni | apoferritin-2 | 0.001 | 0.0108 | 0.0108 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0074 | 0.1403 | 0.1403 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0019 | 0.0288 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0787 | 0.5 |
Brugia malayi | Isocitrate dehydrogenase | 0.0019 | 0.0288 | 0.0709 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0019 | 0.0288 | 0.0216 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0787 | 0.5 |
Echinococcus multilocularis | geminin | 0.0205 | 0.4083 | 0.4039 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.074 | 0.2557 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0288 | 0.0215 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0787 | 0.5 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0288 | 0.0215 |
Treponema pallidum | bacterioferrin (TpF1) | 0.001 | 0.0108 | 0.5 |
Mycobacterium ulcerans | bacterioferritin BfrB | 0.001 | 0.0108 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | bacterioferritin/cytochrome b1 | 0.001 | 0.0108 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0787 | 0.0787 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0019 | 0.0288 | 0.0702 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.1028 | 0.1028 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0288 | 0.0215 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0118 | 0.0044 |
Echinococcus granulosus | expressed protein | 0.001 | 0.0108 | 0.0033 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0288 | 0.0216 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0019 | 0.0288 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1129 | 0.4158 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0019 | 0.0288 | 0.5 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0035 | 0.0608 | 0.2013 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0288 | 0.0288 |
Schistosoma mansoni | ferritin light chain | 0.001 | 0.0108 | 0.0108 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0288 | 0.0288 |
Brugia malayi | CXXC zinc finger family protein | 0.0035 | 0.0608 | 0.2011 |
Loa Loa (eye worm) | helix-loop-helix DNA-binding domain-containing protein | 0.013 | 0.2551 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.1028 | 0.0961 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.074 | 0.074 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.0608 | 0.0608 |
Schistosoma mansoni | ferritin | 0.001 | 0.0108 | 0.0108 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.1028 | 0.0961 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0288 | 0.0216 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.4083 | 0.4083 |
Echinococcus granulosus | geminin | 0.0205 | 0.4083 | 0.4039 |
Brugia malayi | Helix-loop-helix DNA-binding domain containing protein | 0.013 | 0.2564 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.4083 | 0.4083 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.0074 | 0.0074 |
Echinococcus granulosus | transcription factor eb | 0.013 | 0.2564 | 0.2508 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.1028 | 0.1028 |
Schistosoma mansoni | hypothetical protein | 0.0494 | 1 | 1 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0019 | 0.0288 | 0.0216 |
Echinococcus multilocularis | ferritin | 0.001 | 0.0108 | 0.0033 |
Echinococcus multilocularis | dnaJ subfamily B | 0.0494 | 1 | 1 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0019 | 0.0288 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0288 | 0.0706 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0787 | 0.2743 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.1028 | 0.1028 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1129 | 0.4158 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | = 13.859 uM | PUBCHEM_BIOASSAY: MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488944] | ChEMBL. | No reference |
AC50 (functional) | = 13.859 uM | PUBCHEM_BIOASSAY: MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488944] | ChEMBL. | No reference |
AC50 (functional) | = 13.859 uM | PUBCHEM_BIOASSAY: MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_DoseNoFile_CherryPick_Activity_Set3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488944] | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.6234 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.8048 uM | PubChem BioAssay. qHTS of Nrf2 Activators: Hit Validation in Primary Assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.8584 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 8.9125 uM | PubChem BioAssay. qHTS of Nrf2 Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.5821 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 14.7157 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 29.081 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.